# Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings

> **NCT00084136** · PHASE4 · COMPLETED · sponsor: **Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections** · enrollment: 1571 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Atazanavir
- **DRUG:** Didanosine (enteric-coated)
- **DRUG:** Efavirenz
- **DRUG:** Emtricitabine
- **DRUG:** Emtricitabine/Tenofovir disoproxil fumarate
- **DRUG:** Lamivudine/Zidovudine

## Key facts

- **NCT ID:** NCT00084136
- **Lead sponsor:** Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 1571 (ACTUAL)
- **Last updated:** 2018-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00084136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00084136, "Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00084136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*